Company news
Bebetter Med, Inc. Class A (SSE:688759) news
Bebetter Med, Inc. Class A news releases on 6ix. Latest, Sep 9, 2026: "BEBETTER MED INC."Announcement on Attending the 2026 Collective Reception Day…
Press releases & updates
"BEBETTER MED INC."Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction
September 8, 2026
"BEBETTER MED INC."Announcement on Change in Accounting Policies
August 24, 2026
"BEBETTER MED INC."Announcement on Abnormal Fluctuations in Stock Trading
July 28, 2026
"BEBETTER MED INC."Announcement on Listing and Trading of Certain Restricted Shares from Offline Placement in the Initial Public Offering
July 20, 2026
Announcement on Opening a Special Account for Raised Funds and Signing a Tripartite Supervision Agreement on Special Account Deposit of Raised Funds
May 29, 2026
Special Report on Deposit, Management, and Actual Use of Raised Funds in 2025
April 27, 2026
Announcement on Circulation of Partial Restricted Shares in Offline Placement of Initial Public Offering
April 20, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
April 8, 2026
Announcement on Changing Some Investment Projects Financed by Raised Funds and the Establishment of a New Special Account for Raised Funds
March 23, 2026
Announcement on Voluntary Disclosure of Obtaining Clinical Trial Approval Notification for Iprinosine Hydrochloride for Injection (BEBT-908) Combined with CHOP in the Treatment of Newly Diagnosed Peripheral T-Cell Lymphoma
March 13, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Opening Special Settlement Account for Cash Management of Raised Funds
February 11, 2026
BEBETTER MED INC." -- Announcement on Voluntary Disclosure of Clinical Trial Applications for BEBT-701 Approved by China NMPA
February 3, 2026
Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
January 29, 2026
Announcement on Expected Loss in Performance for 2025
January 23, 2026
Announcement on Abnormal Fluctuations in Stock Trading
January 7, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
November 28, 2025
Announcement on Changing Registered Capital and Business Type, Amending the Articles of Association and Handling Industrial and Commercial Change Registration
November 12, 2025